We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » India Proposes National Authority to Oversee, Promote Medical Devices

India Proposes National Authority to Oversee, Promote Medical Devices

June 12, 2015

The Indian government is creating a dedicated authority to oversee the regulation and production of medical devices, taking the first steps to separate the sector from the nation’s pharmaceutical regulatory regime.

The plan is the latest attempt by the government to improve device quality in the absence of statutory regulations. Efforts to pass regulations in Parliament have failed repeatedly and registration of devices is limited to certain product categories under the country’s drug laws.

India would also like to get a bigger slice of the global medtech pie. The government estimates its local industry contributes about $4.8 billion of the $220 billion worldwide market and most of its business is in disposables and medical supplies. About 65 percent of the country’s medical devices, including nearly all implantable devices, are imported.

The government is considering offering incentives to the device industry, such as preferred purchasing of locally made devices, seed capital and viability gap funding, tariffs and revised tax and duty structures to attract new companies and have existing companies expand.

The National Medical Device Authority is to be headed by a cabinet-level secretary or joint secretary and housed within the Department of Pharmaceuticals.

Its responsibilities include setting up and managing medical device mega parks throughout the country, creating manufacturing benchmarks based on international best practices and partnering with industry to develop knowledge networks.

The government is seeking comment from industry groups through July 15.

View the draft policy at www.fdanews.com/06-15-15-india.pdf. — Elizabeth Orr

Regulatory Affairs

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • WhiteHouse.gif

    President Biden Issues Executive Order on U.S. Supply Chain

  • roche.gif

    Priority Healthcare Settles Diabetes Test Lawsuit with Roche for $43 Million

  • Effective text

    Pfizer/BioNTech Vaccine Equally Effective for All Age Groups, Israeli Study Says

  • Siemens Healthineers logo

    Siemens Healthineers’ COVID-19 Antigen Lab Test Receives CE Mark

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing